CA2030178A1 - Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif - Google Patents

Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif

Info

Publication number
CA2030178A1
CA2030178A1 CA2030178A CA2030178A CA2030178A1 CA 2030178 A1 CA2030178 A1 CA 2030178A1 CA 2030178 A CA2030178 A CA 2030178A CA 2030178 A CA2030178 A CA 2030178A CA 2030178 A1 CA2030178 A1 CA 2030178A1
Authority
CA
Canada
Prior art keywords
buprenorphine
transdermal therapeutic
therapeutic system
active component
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2030178A
Other languages
English (en)
Other versions
CA2030178C (fr
Inventor
Thomas Hille
Lothar Deurer
Hans-Rainer Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6394373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2030178(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of CA2030178A1 publication Critical patent/CA2030178A1/fr
Application granted granted Critical
Publication of CA2030178C publication Critical patent/CA2030178C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
CA002030178A 1989-11-29 1990-11-16 Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif Expired - Lifetime CA2030178C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3939376A DE3939376C1 (fr) 1989-11-29 1989-11-29
DEP3939376.3-41 1989-11-29

Publications (2)

Publication Number Publication Date
CA2030178A1 true CA2030178A1 (fr) 1991-05-30
CA2030178C CA2030178C (fr) 1995-08-15

Family

ID=6394373

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002030178A Expired - Lifetime CA2030178C (fr) 1989-11-29 1990-11-16 Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif

Country Status (25)

Country Link
EP (1) EP0430019B1 (fr)
JP (1) JPH0818984B2 (fr)
KR (1) KR950015061B1 (fr)
AT (1) ATE135205T1 (fr)
AU (1) AU632182B2 (fr)
CA (1) CA2030178C (fr)
CZ (1) CZ282557B6 (fr)
DE (2) DE3939376C1 (fr)
DK (1) DK0430019T3 (fr)
ES (1) ES2086353T3 (fr)
FI (1) FI100379B (fr)
GR (1) GR3020177T3 (fr)
HR (1) HRP930675B1 (fr)
HU (1) HU206266B (fr)
IE (1) IE73247B1 (fr)
IL (1) IL96243A (fr)
MY (1) MY105347A (fr)
NO (1) NO303107B1 (fr)
NZ (1) NZ236191A (fr)
PL (1) PL165396B1 (fr)
PT (1) PT96028B (fr)
SI (1) SI9012260B (fr)
SK (1) SK279687B6 (fr)
YU (1) YU47956B (fr)
ZA (1) ZA909544B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6868286B1 (en) 1998-11-03 2005-03-15 Lts Lohmann Therapie-Systeme Ag Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
US6344211B1 (en) 1994-12-24 2002-02-05 Lts Lohmann Therapie-Systeme Gmbh Transdermal absorption of active substances from subcooled melts
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
JPH1036265A (ja) 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
DE19705138A1 (de) 1997-02-11 1998-08-13 Lohmann Therapie Syst Lts Dehnbares transdermales therapeutisches System
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19738855C2 (de) 1997-09-05 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
DE10056012A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Flexible Barrierefolie für ein Trägermaterial für medizinische Zwecke
DE10056014A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme
JP4194277B2 (ja) 2002-01-25 2008-12-10 久光製薬株式会社 架橋ポリマーを主成分とする粘着性成形体の製造方法
DE10237057A1 (de) * 2002-08-09 2004-03-25 Grünenthal GmbH Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
EP1526848B1 (fr) * 2002-08-09 2007-07-18 Grünenthal GmbH Antagonistes du recepteur opioide dans des systemes transdermiques a base de buprenorphine
PT1610791E (pt) 2003-03-31 2011-05-23 Titan Pharmaceuticals Inc Dispositivo polim?rico implant?vel para liberta??o sustentada de agonista da dopamina
ATE375149T1 (de) * 2003-07-25 2007-10-15 Euro Celtique Sa Behandlung von entzug
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
EP1743638A1 (fr) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Formulations pharmaceutiques des derivés de la pyrazoline
DE102006057083A1 (de) 2005-12-05 2007-06-28 Lg Electronics Inc. Beleuchtungsvorrichtung für einen Kühlschrank
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
AU2011331511C1 (en) * 2010-11-17 2018-01-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
DE102011076653A1 (de) 2011-05-27 2012-11-29 Acino Ag Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure
EA201491164A1 (ru) * 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
AP2015008920A0 (en) 2013-06-04 2015-12-31 Lohmann Therapie Syst Lts Transdermal delivery system
DE102014013448A1 (de) 2014-09-16 2016-03-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales Therapeutisches System umfassend Buprenorphin
US9656441B2 (en) 2015-01-08 2017-05-23 Alfred E. Tiefenbacher ( Gmbh & Co. Kg) Transdermal patch
EP3067050A1 (fr) 2015-03-13 2016-09-14 Acino AG Système thérapeutique transdermique avec bande de recouvrement comprenant deux couches adhésives
CN109045341A (zh) * 2018-05-07 2018-12-21 武汉兴嘉业堂医疗科技发展有限公司 一种活血止痛压敏胶及其制备方法、应用
CN116134577A (zh) * 2020-07-22 2023-05-16 佳能安内华股份有限公司 离子枪和真空处理设备

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
JPS632533A (ja) * 1986-06-23 1988-01-07 Yamakawa Sangyo Kk 精密鋳造用鋳物砂
CH672888A5 (fr) * 1986-11-07 1990-01-15 Mepha Ag
DE3862405D1 (de) * 1987-03-09 1991-05-23 Alza Corp Zusammensetzung zur vorbeugung einer kontaktallergie durch gleichzeitiges verabreichen eines kortikosteroids mit einem sensiblisierenden arzneistoff.
EP0375689B1 (fr) * 1987-06-01 1992-08-12 Warner-Lambert Company Composition pharmaceutique adaptee a l administration transdermique d'un medicament opioid.
DE3843237A1 (de) * 1988-12-22 1990-07-05 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6868286B1 (en) 1998-11-03 2005-03-15 Lts Lohmann Therapie-Systeme Ag Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application

Also Published As

Publication number Publication date
YU47956B (sh) 1996-07-24
PT96028B (pt) 1998-02-27
PT96028A (pt) 1991-09-13
HRP930675B1 (en) 1999-10-31
CA2030178C (fr) 1995-08-15
NO905103D0 (no) 1990-11-26
HUT55643A (en) 1991-06-28
IL96243A0 (en) 1991-08-16
GR3020177T3 (en) 1996-09-30
NO303107B1 (no) 1998-06-02
DE59010192D1 (de) 1996-04-18
DK0430019T3 (da) 1996-07-22
CZ282557B6 (cs) 1997-08-13
EP0430019A2 (fr) 1991-06-05
JPH03193732A (ja) 1991-08-23
SK279687B6 (sk) 1999-02-11
IE904290A1 (en) 1991-06-05
ATE135205T1 (de) 1996-03-15
JPH0818984B2 (ja) 1996-02-28
KR910009249A (ko) 1991-06-28
IE73247B1 (en) 1997-05-21
ES2086353T3 (es) 1996-07-01
HU206266B (en) 1992-10-28
HRP930675A2 (en) 1994-10-31
FI100379B (fi) 1997-11-28
AU632182B2 (en) 1992-12-17
ZA909544B (en) 1992-08-26
NZ236191A (en) 1993-05-26
PL287989A1 (en) 1991-09-09
FI905892A0 (fi) 1990-11-29
FI905892L (fi) 1991-05-30
DE3939376C1 (fr) 1991-05-08
EP0430019A3 (en) 1991-09-18
AU6569990A (en) 1991-06-06
MY105347A (en) 1994-09-30
CS9005598A2 (en) 1991-12-17
NO905103L (no) 1991-05-30
EP0430019B1 (fr) 1996-03-13
SI9012260A (en) 1997-10-31
KR950015061B1 (ko) 1995-12-21
IL96243A (en) 1994-11-28
SI9012260B (sl) 1998-06-30
PL165396B1 (en) 1994-12-30
YU226090A (sh) 1992-12-21

Similar Documents

Publication Publication Date Title
CA2030178A1 (fr) Dispositif therapeutique transdermique faisant appel a la buprenorphine comme composant actif
CA2153572A1 (fr) Systeme therapeutique pour administration transdermique, avec la galanthamine comme principe actif
AU6940191A (en) Transdermal therapeutic system comprising tulobuterol as active substance
CA2387143A1 (fr) Systeme therapeutique transdermique a base d'hydrochlorure de tulobuterol utilise pour administrer le bronchodilatateur tulobuterol par l'intermediaire de la peau
MY110391A (en) Nitroglycerin-containing patch, a process for the production and the use thereof
WO1994025025A3 (fr) Systemes permettant la liberation regulee de pilocarpine
MY105074A (en) Transdermal therapeutical system comprising norpseudoephedrine as active component.
CA2147274A1 (fr) Dispositif d'administration transdermique de physostigmine et methode de fabrication de ce dispositif

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry